Akos Czibere
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Akos Czibere currently works at Aktis Oncology, Inc., as Chief Medical Officer from 2024.
Dr. Czibere also formerly worked at Merrimack Pharmaceuticals, Inc., as Vice President-Clinical Development and Pfizer Inc., as Vice President-Therapeutic Area.
Dr. Czibere received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. -.--% | 23/09/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national